{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:11:46Z","timestamp":1761293506396,"version":"3.37.3"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NR-45859"],"award-info":[{"award-number":["NR-45859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"investigator initiated research","award":["Merck"],"award-info":[{"award-number":["Merck"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/jac\/dkw588","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T15:06:04Z","timestamp":1482591964000},"page":"1410-1414","source":"Crossref","is-referenced-by-count":14,"title":["Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis"],"prefix":"10.1093","volume":"72","author":[{"given":"Brian J.","family":"Werth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"key":"key\n\t\t\t\t20180328160006_dkw588-B1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archinternmed.2012.1690","article-title":"Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia","volume":"172","author":"Carratala","year":"2012","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20180328160006_dkw588-B2","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","article-title":"Linezolid: a review of safety and tolerability","volume":"59","author":"Vinh","year":"2009","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/AAC.03684-14","article-title":"Evaluation of the potential of tedizolid and linezolid to affect mitochondrial function using nonclinical and pharmacokinetic assessments","volume":"59","author":"Flanagan","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-015-0060-3","article-title":"Tedizolid phosphate: a next-generation oxazolidinone","volume":"4","author":"Rybak","year":"2015","journal-title":"Infect Dis Ther"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)16727-5","article-title":"Osteomyelitis","volume":"364","author":"Lew","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B7","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00455-10","article-title":"Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm","volume":"54","author":"Parra-Ruiz","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement M100-S25","year":"2015","author":"Clinical and Laboratory Standards Institute","key":"key\n\t\t\t\t20180328160006_dkw588-B8"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B9","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/AAC.02354-12","article-title":"Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B10","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/jac\/dku236","article-title":"Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes","volume":"69","author":"Barber","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/inf.1973.5.issue-3.07","article-title":"Studies on doxycycline during intravenous and oral treatment with reference to renal function","volume":"5","author":"Alestig","year":"1973","journal-title":"Scand J Infect Dis"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000221822","article-title":"Investigations on plasma levels of sulfamethoxazole in man after single and chronic oral administration alone and in combination with trimethoprim","volume":"20","author":"Nolte","year":"1974","journal-title":"Chemotherapy"},{"volume-title":"Product Information: AVELOX(R) oral tablet injection, moxifloxacin hydrochloride oral tablet sodium chloride injection","year":"2008","key":"key\n\t\t\t\t20180328160006_dkw588-B13"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1378\/chest.115.1.12","article-title":"Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids","volume":"115","author":"Peloquin","year":"1999","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2004.02.021","article-title":"Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus","volume":"24","author":"Metzler","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000069779","article-title":"Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae","volume":"49","author":"Lemmen","year":"2003","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dku386","article-title":"Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE","volume":"70","author":"Werth","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1086\/367661","article-title":"Combination antibiotic therapy for infective endocarditis","volume":"36","author":"Le","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B19","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.47.6.1902-1906.2003","article-title":"In vitro activities of linezolid combined with other antimicrobial agents against staphylococci, enterococci, pneumococci, and selected gram-negative organisms","volume":"47","author":"Sweeney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/jac\/dkv481","article-title":"Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention","volume":"71","author":"Tornero","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B21","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.47.1.418-420.2003","article-title":"In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus","volume":"47","author":"Grohs","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328160006_dkw588-B22","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Antagonism between bacteriostatic and bactericidal antibiotics is prevalent","volume":"58","author":"Ocampo","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/5\/1410\/24332078\/dkw588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T23:35:01Z","timestamp":1522280101000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/5\/1410\/2965584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,1,31]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw588","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,1,31]]}}}